EDITORIAL COMMENT
- PMID: 35843703
- DOI: 10.1016/j.urology.2021.08.073
EDITORIAL COMMENT
Comment in
-
AUTHOR REPLY.Urology. 2022 Jul;165:97. doi: 10.1016/j.urology.2021.08.074. Urology. 2022. PMID: 35843704 No abstract available.
Comment on
-
Disparities in the Treatment and Survival of Metastatic Renal Cell Carcinoma.Urology. 2022 Jul;165:89-97. doi: 10.1016/j.urology.2021.08.070. Epub 2021 Nov 20. Urology. 2022. PMID: 34808140
Publication types
LinkOut - more resources
Full Text Sources
